| Overview |
| bsm-90190r-50µL |
| Cystatin C Recombinant Antbody Kit (KD-Validated) |
| WB, IC |
| Knockdown Validated |
| Human, Mouse |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Cystatin C |
| 1-146/146 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 1471 |
| P01034 |
| CST3; Cystatin C; Neuroendocrine Basic Polypeptide; Post-Gamma-Globulin; Gamma-Trace; Cystatin-C; Cystatin C (Amyloid Angiopathy And Cerebral Hemorrhage); Epididymis Secretory Protein Li; BA218C14.4 (Cystatin C); Cystatin 3; Cystatin-3; HEL-S-2 3; ARMD11 |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| IC |
1:1000 |